Abnormalp53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
Histological Grading and Prognosis in Breast Cancer
1957 • 2,897 citations
Mutations in the p53 gene occur in diverse human tumour types
1989 • 2,765 citations
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.
1983 • 2,066 citations
The p53 proto-oncogene can act as a suppressor of transformation
1989 • 2,019 citations
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
1988 • 1,140 citations
Diagnostic Histopathology of the Breast
1988 • 1,083 citations
Increased expression of mutant forms of p53 oncogene in primary lung cancer
1990 • 1,045 citations
p53: oncogene or anti-oncogene?
1990 • 812 citations
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
1984 • 761 citations
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
1984 • 754 citations
Clonal Analysis of Human Colorectal Tumors
1987 • 638 citations
P53 expression in breast cancer
1988 • 612 citations
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
1990 • 607 citations
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
1984 • 606 citations
Microvessel quantitation and prognosis in invasive breast carcinoma
1992 • 566 citations
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
1991 • 512 citations
Localization of gene for human p53 tumour antigen to band 17p13
1986 • 498 citations
Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.
1987 • 487 citations
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
1985 • 380 citations
How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients
1990 • 323 citations
Activating Mutations for Transformation by p53 Produce a Gene Product That Forms an hsc70-p53 Complex with an Altered Half-Life
1988 • 298 citations
Genetic basis for p53 overexpression in human breast cancer.
1991 • 287 citations
Maintenance of p53 alterations throughout breast cancer progression.
1991 • 244 citations
p53 expression in colorectal tumors.
1991 • 243 citations
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS
1988 • 236 citations
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
1991 • 200 citations
Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast.
1990 • 154 citations
Relation between p53 overexpression and established prognostic factors in breast cancer.
1991 • 149 citations
Expression of p53 protein in infiltrating and in‐situ breast carcinomas
1991 • 145 citations
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer
1990 • 120 citations
p53 Cellular Tumor Antigen: Analysis of mRNA Levels in Normal Adult Tissues, Embryos, and Tumors
1985 • 117 citations
Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms
1992 • 114 citations
Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.
1990 • 105 citations
Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors.
1991 • 63 citations
DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
1992 • 37 citations
Abnormal p53 Expression in Lung Neuroendocrine Tumors Diagnostic and Prognostic Implications
1992 • 35 citations
Abnormal p53 Expression in Lung Neuroendocrine Tumors Diagnostic and Prognostic Implications
1992 • 35 citations
Cited By (0)
No citing papers found in database